Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (437)	12/8/2003 10:29:45 AM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

BAX Is showing some upward activity this morning after it received an upgrade from Merrill Lynch.<g> siliconinvestor.com ALKS Closed yesterday's upgap and is now trading to the downside in spite of reporting good results from its PIII study of Vivitrex in males with alcohol dependence, which showed a 48% reduction in rate of heavy drinking relative to placebo. No benefits were observed in the female group.<g> siliconinvestor.com Bernard

To: Jibacoa who wrote (437)	12/22/2003 1:04:11 PM
From: Jibacoa	Read Replies (2) \| Respond to of 3722

NGEN Is up a modest 11.75% on volume over 2M after articles about nanotechnology on SmartMoney on Friday and the NY Times today, in which the company was mentioned, although the NY Times article said that some nanotechnology results maybe yet a generation away.<g> bigcharts.marketwatch.com The stock doesn't seem inclined to close its December 3rd upgap and as I mentioned before, it still has some room to run.<g> bigcharts.marketwatch.com Bernard